expanded access

(redirected from Compassionate use trial)

expanded access

Any of several methods used by the FDA to make experimental treatments available to patients who have failed conventional treatments and are not participating in formal clinical trials.
References in periodicals archive ?
This Phase I/IIa trial follows a compassionate use trial conducted in Israel with a patient suffering from ovarian cancer characterized by intra-peritoneal distribution of metastases and ascites, who failed conventional chemotherapy treatment.
NASDAQ:PRLN) today announced that as a result of the "very encouraging" results from its initial compassionate use trial for its PN 27,1, the company is expanding the trial to encompass 300 patients.
Babish noted that in the initial compassionate use trial for PN 27,1, Paracelsian's anticancer drug, which has been found to effectively block the secretion of prostate-specific antigen and the growth of prostate cancer cells in vitro, seven patients took the drug: two for non-Hodgkin's lymphoma, two for breast cancer and two for prostate cancer.
Babish, potential participants in the expanded compassionate use trial may call him at the company, 607/257-4224 to discuss whether they meet the appropriate criteria for participation.
NASDAQ: PRLN) today announced preliminary results of its compassionate use trial for its anti-cancer drug, PN 27.
Currently the company has compassionate use trials underway for its compound PN 27, 1, which has been found to have safe and effective activity against prostate and breast cancers and non-Hodgkin's lymphomas, as well as initial clinical trials at the Bastyr University in Seattle for its PN 355 compound, which has been found to have specific activity against HIV.
Currently the company has compassionate use trials under way for its compound PN 27,1, which has been found to have safe and effective activity against prostate and breast cancers and non-Hodgkin's lymphomas, as well as clinical trials at the Bastyr University in Seattle for its compounds PN 355 that has demonstrated in vitro activity against HIV.